CMOs- Supporting the Pharma Industry The Indian pharma industry has shown tremendous progress on several indices such as infrastructure, technology, product range, GMP, regulation compliant manufacturing facilities. Also, the high quality standards of purity; stability and international safety; health and environmental protection under which bulk active ingredients are manufactured and supplied by Indian pharmaceutical companies ensure that they will pass through several rounds of stringent assessment by various regulatory authorities. India has already gained a foothold in the global arena of export due to its high proficiency in manufacturing fantastic quality of drug products. Moreover due to the high number of CMOs available, Indian pharma is looking for better prospects.
The BioSpectrum India edition was launched in March 2003 and is India's first comprehensive biotech business monthly magazine. It provides comprehensive coverage of the exciting happenings in life sciences, which include BioPharma, BioAgriculture, BioInformatics, BioIndustrial, BioSuppliers and BioServices and show cases the emerging Indian entrepreneurships in biotech industry. In a short time BioSpectrum has emerged as the most preferred platform to engage the life sciences industry in India and Asia Pacific. It is also widely accepted by research and academia community. Top key policy makers in the Central and state government use the magazine as a platform to reach out the Indian Biotech Industry. BioSpectrum has columns by Indian's top policy makers, biotechnology professionals, scientists and NGOs. Readers of BioSpectrum are from among the key Policy Makers, Key Executives and the Influencer's in Biotechnology, Pharmaceutical Companies, Research Heads of Clinical Research, Clinical Trials and Contract Mfg Organizations, Educational Institutes, Consultants, Fund Managers etc